Ankylosing spondylitis in West Africans--evidence for a non-HLA-B27 protective effect
about
Prevalence of Arthritis in Africa: A Systematic Review and Meta-AnalysisAnkylosing spondylitis in a MalawianOld and new HLA associations with ankylosing spondylitis.Safety of tumor necrosis factor inhibitors use for rheumatoid arthritis and ankylosing spondylitis in Africa, the Middle East, and Asia: focus on severe infections and tuberculosis.Epidemiology of spondyloarthritis: a review.Spondyloarthritis in sub-Saharan Africa.Raised incidence of ankylosing spondylitis among Inuit populations could be due to high HLA-B27 association and starch consumption.Peptide handling by HLA-B27 subtypes influences their biological behavior, association with ankylosing spondylitis and susceptibility to endoplasmic reticulum aminopeptidase 1 (ERAP1).Polymorphisms of HLA-A, -B, -Cw and DRB1 antigens in Moroccan patients with ankylosing spondylitis and a comparison of clinical features with frequencies of HLA-B*27.Transcriptome analysis of ankylosing spondylitis patients before and after TNF-α inhibitor therapy reveals the pathways affected.Ethnicity and disease severity in ankylosing spondylitis a cross-sectional analysis of three ethnic groups.The distribution of HLA-B27 subtype in patients with ankylosing spondylitis in Northern Norway.Association of ankylosing spondylitis with HLA-B*1403 in a West African population.Progress of genome-wide association studies of ankylosing spondylitis.Spondyloarthritis in the Democratic Republic of the Congo: a prospective hospital-based study.
P2860
Q26799121-29D8BC37-A957-49B7-97B4-94BCD5454B11Q35937413-E2770842-C684-4BFB-B409-4A8E984F5894Q38033598-AA1AC83B-3CD3-41D4-AE72-D47FFCBCF9A8Q38067609-73D3F759-688A-48D5-9CD9-9C2A158D1A73Q38124275-10384718-E828-48A2-8F36-0BC1B87285BDQ38205390-A149ADFB-DD31-414E-83C3-5A5AA3567D07Q38266805-A2F96872-9CF3-45A5-B347-A91EEDE77CEFQ38959953-64BFFDC5-97A7-421F-8A78-D18271077924Q38985290-2250FB5C-8295-4392-A7E9-E912EAE08F5CQ40081875-97C959C0-99C5-43C4-93D9-F3C9C77B5084Q43912244-306B9C3D-B2D0-4441-8BEC-D9A7E76DC9A8Q44263137-4922D12B-9F8E-4862-A46C-08E3E2707834Q46946757-BCD0DBF9-CAAA-4DAC-A4B2-568CD7F90D2CQ49871790-5DC7F38C-18D5-4ED1-A521-40A53DE2B44AQ54951103-284847D0-2A43-420A-8776-84A7EB9A4AD5
P2860
Ankylosing spondylitis in West Africans--evidence for a non-HLA-B27 protective effect
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Ankylosing spondylitis in West Africans--evidence for a non-HLA-B27 protective effect
@ast
Ankylosing spondylitis in West Africans--evidence for a non-HLA-B27 protective effect
@en
type
label
Ankylosing spondylitis in West Africans--evidence for a non-HLA-B27 protective effect
@ast
Ankylosing spondylitis in West Africans--evidence for a non-HLA-B27 protective effect
@en
prefLabel
Ankylosing spondylitis in West Africans--evidence for a non-HLA-B27 protective effect
@ast
Ankylosing spondylitis in West Africans--evidence for a non-HLA-B27 protective effect
@en
P2093
P356
P1476
Ankylosing spondylitis in West Africans--evidence for a non-HLA-B27 protective effect
@en
P2093
P356
10.1136/ARD.56.1.68
P407
P577
1997-01-01T00:00:00Z